INVO Fertility, Inc. splits its revenue into 2 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Clinic Revenue at $2.2 million, 100% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jun 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
| Clinic Revenue |
7
+13.1%
share 98.5%
|
2
+18.3%
share 99.6%
|
2
+22.2%
share 98.4%
|
2
-8.4%
share 97.6%
|
2
+21.5%
share 98.0%
|
2
share 98.3%
|
2
share 99.0%
|
2
share 98.4%
|
1
share 98.9%
|
| Product |
0
+86.4%
share 1.5%
|
0
-75.6%
share 0.4%
|
0
+111.1%
share 1.6%
|
0
+2958.3%
share 2.4%
|
0
+130.3%
share 2.0%
|
0
share 1.7%
|
0
share 1.0%
|
-0
share -0.1%
|
0
share 1.1%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IVF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1417926
- Former names
- NAYA Biosciences, Inc. (until Apr 14, 2025); INVO Bioscience, Inc. (until Oct 15, 2024); EMY'S SALSA AJI DISTRIBUTION COMPANY, INC. (until Jan 5, 2009)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.